Cleversey Chantell, Robinson Meghan, Willerth Stephanie M
Doctor of Medicine (MD), Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Department of Urological Sciences, Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.
Micromachines (Basel). 2019 Jul 27;10(8):501. doi: 10.3390/mi10080501.
Breast cancer often results in the removal of the breast, creating a need for replacement tissue. Tissue engineering offers the promise of generating such replacements by combining cells with biomaterial scaffolds and serves as an attractive potential alternative to current surgical repair methods. Such engineered tissues can also serve as important tools for drug screening and provide in vitro models for analysis. 3D bioprinting serves as an exciting technology with significant implications and applications in the field of tissue engineering. Here we review the work that has been undertaken in hopes of generating the recognized in-demand replacement breast tissue using different types of bioprinting. We then offer suggestions for future work needed to advance this field for both in vitro and in vivo applications.
乳腺癌常常导致乳房被切除,从而产生对替代组织的需求。组织工程有望通过将细胞与生物材料支架相结合来生成此类替代物,并成为当前手术修复方法颇具吸引力的潜在替代方案。这种工程化组织还可作为药物筛选的重要工具,并提供体外分析模型。3D生物打印是一项令人兴奋的技术,在组织工程领域具有重大意义和应用价值。在此,我们回顾了为使用不同类型的生物打印来生成公认的急需替代乳房组织所开展的工作。然后,我们针对推进该领域在体外和体内应用所需的未来工作提出建议。